De novo synthesis of a narrow size distribution low-molecular-weight heparin.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Glycobiology

• Publication date

  2014-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/glycob/cwu016PMID 24626379PMCID PMC3976284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigation of the substrate specificity of K5 lyase A from K5A bacteriophage.

  2013cited by this paper
• Use of biosynthetic enzymes in heparin and heparan sulfate synthesis.

  2013cited by this paper
• Synthetic heparin.

  2012cited by this paper
• Probing Structural Selectivity of Synthetic Heparin Binding to Stabilin Protein Receptors*

  2012cited by this paper
• Chemoenzymatic Synthesis of Heparin Oligosaccharides with both Anti-factor Xa and Anti-factor IIa Activities*

  2012cited by this paper
• Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin

  2012cited by this paper
• Uncovering Biphasic Catalytic Mode of C5-epimerase in Heparan Sulfate Biosynthesis*

  2012cited by this paper
• Structure/Function Analysis of Pasteurella multocida Heparosan Synthases

  2012influential reference
• Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins

  2011cited by this paper
• Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfate.

  2011cited by this paper
• Chemoenzymatic Design of Heparan Sulfate Oligosaccharides*

  2010cited by this paper
• Analysis of the Polymerization Initiation and Activity of Pasteurella multocida Heparosan Synthase PmHS2, an Enzyme with Glycosyltransferase and UDP-sugar Hydrolase Activity*

  2010cited by this paper
• Derivation of neural crest cells from human pluripotent stem cells

  2010cited by this paper
• Derivation of neural crest cells from human pluripotent stem cells

  2010cited by this paper
• Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.

  2010cited by this paper
• Structural features of low-molecular-weight heparins affecting their affinity to antithrombin

  2009cited by this paper
• BIOTECHNOLOGICALLY RELEVANT ENZYMES AND PROTEINS In vitro synthesis of heparosan using recombinant Pasteurella multocida heparosan synthase PmHS2

  2009cited by this paper
• Design of biologically active heparan sulfate and heparin using an enzyme-based approach.

  2009cited by this paper
• Design of Biologically Active Heparan Sulfate and Heparin Using an Enzyme‐Based Approach

  2009cited by this paper
• Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation.

  2008cited by this paper
• Chemoenzymatic Synthesis with Distinct Pasteurella Heparosan Synthases

  2007influential reference
• Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.

  2007cited by this paper
• Characterization of the N-deacetylase domain from the heparan sulfate N-deacetylase/N-sulfotransferase 2.

  2006cited by this paper
• Determination of the substrate specificities of N-acetyl-d-glucosaminyltransferase.

  2006cited by this paper
• The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5.

  2004cited by this paper
• Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004influential reference
• Synchronized Chemoenzymatic Synthesis of Monodisperse Hyaluronan Polymers*

  2004cited by this paper
• The Clinical Onset of Heparin Is Rapid

  2001cited by this paper
• Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.

  2000cited by this paper
• Synthesis of thrombin-inhibiting heparin mimetics without side effects

  1999cited by this paper
• Production and chemical processing of low molecular weight heparins.

  1999cited by this paper
• Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

  1998cited by this paper
• Low-molecular-weight heparins: pharmacologic profile and product differentiation.

  1998cited by this paper
• Purification of Heparan Sulfate D-Glucosaminyl 3-O-Sulfotransferase*

  1996cited by this paper
• Appropriate Use of Low-Molecular-Weight Heparins (LMWHs)

  1993cited by this paper
• Heparin and low-molecular weight heparins

  1992cited by this paper
• Quantum leap?

  1991cited by this paper
• Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs.

  1991cited by this paper
• Location of the antithrombin-binding sequence in the heparin chain.

  1989cited by this paper
• Formation of anhydrosugars in the chemical depolymerization of heparin.

  1976cited by this paper

• Synthetic biology for heparin biomanufacturing

  2026cites this paper
• Heparin and heparin-like modifications in hemodialysis membranes: Current innovations and future directions.

  2025cites this paper
• Overview of the current procedures in synthesis of heparin saccharides.

  2024cites this paper
• Effects of Lactobacillus fermentation on Eucheuma spinosum polysaccharides: Characterization and mast cell membrane stabilizing activity.

  2023cites this paper
• Polysaccharide isolated from Korean-style soy sauce activates macrophages via the MAPK and NK-κB pathways

  2021cites this paper
• Heparin mimetics as tools for modulation of biology and therapy

  2020cites this paper
• Chemoenzymatic synthesis of ultralow and low-molecular weight heparins.

  2020cites this paper
• Advances in the preparation and synthesis of heparin and related products.

  2020cites this paper
• Complex Natural Product Heparin: Biosynthesis, Biology, and Application via Synthetic Heparins

  2019cites this paper
• Signaling pathways associated with macrophage-activating polysaccharides purified from fermented barley.

  2019cites this paper
• Analysis of sulfates on low molecular weight heparin using mass spectrometry: structural characterization of enoxaparin

  2018influential citation
• Heparin mimetics with anticoagulant activity

  2018cites this paper
• Metabolic engineering of Bacillus subtilis for biosynthesis of heparosan using heparosan synthase from Pasteurella multocida, PmHS1

  2017cites this paper
• METHODS FOR COST-EFFECTIVE SYNTHESIS OF HEPARAN SULFATE POLYSACCHARIDES

  2016cites this paper
• The design and synthesis of new synthetic low‐molecular‐weight heparins

  2016cites this paper
• Toll-like receptor 4-related immunostimulatory polysaccharides: Primary structure, activity relationships, and possible interaction models.

  2016cites this paper
• High-throughput assays of leloir-glycosyltransferase reactions: The applications of rYND1 in glycotechnology.

  2016cites this paper
• Can We Produce Heparin/Heparan Sulfate Biomimetics Using “Mother-Nature” as the Gold Standard?

  2015cites this paper
• Chemoenzymatic synthesis of heparan sulfate and heparin.

  2014cites this paper